- Home
- HYFT
as 10-24-2025 3:55pm EST
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
| Founded: | 1983 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 80.8M | IPO Year: | 2017 |
| Target Price: | N/A | AVG Volume (30 days): | 614.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.55 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.27 - $3.25 | Next Earning Date: | 12-09-2025 |
| Revenue: | $18,214,531 | Revenue Growth: | 18.33% |
| Revenue Growth (this year): | -25.74% | Revenue Growth (next year): | 71.78% |
Latest MindWalk Holdings Corp. Common Stock News
HYFT Breaking Stock News: Dive into HYFT Ticker-Specific Updates for Smart Investing
Business Wire
6 days ago
MindWalk Appoints R. Scott Areglado as Chief Financial Officer to Strengthen Financial Leadership and Support Growth Strategy
Business Wire
12 days ago
MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion
Business Wire
18 days ago
MindWalk Announces Share Repurchase Program
Insider Monkey
a month ago
MindWalk Holdings Corp. (HYFT) Surges with 45% Revenue Growth and Strategic AI-Focused Rebrand
Business Wire
a month ago
MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity
Compare HYFT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HYFT MindWalk Holdings Corp. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.